Hereditary hypo/de-pigmented dermatoses: An overview

International Journal of Dermatology

Volumn 47, Issue 10, 2008, Pages 1041-1050

  Sehgal, Virendra N ^a,b   Srivastava, Govind ^a  

^a Sehgal Nursing Home   (India)

^b NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALBINISM; ALBINOIDISM; AMELANOTIC NEVUS; ATHETOSIS; CHEDIAK HIGASHI SYNDROME; CLINICAL FEATURE; DEPIGMENTATION; GENE MUTATION; GENETIC DISORDER; GRISCELLI PRUNIERAS SYNDROME; HALO NEVUS; HAPPY PUPPET SYNDROME; HISTOPATHOLOGY; HUMAN; HYPOPIGMENTATION; INCONTINENTIA PIGMENTI; LOWE SYNDROME; MENTAL DEFICIENCY; MORBIDITY; MUTATIONAL ANALYSIS; NONHUMAN; OCULAR ALBINISM; PHENYLKETONURIA; PIEBALDISM; PRADER WILLI SYNDROME; RESTLESSNESS; REVIEW; SEIZURE; SKIN DISEASE; TIETZE SYNDROME; TUBEROUS SCLEROSIS; VITILIGO; WAARDENBURG SYNDROME;

GENETIC DISEASES, INBORN; GENETIC VARIATION; HUMANS; PIGMENTATION DISORDERS;

EID: 54749132351     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.03105.x     Document Type: Review

References (119)

1. Spritz RA, Hearing VJ Jr. Genetic disorders of pigmentation. Adv Hum Genet 1994; 22: 1-45.
2. Witkop CJ. Dipigmentation of the general and oral tissues and their genetic foundations. Ala J Med Sci 1979; 16: 330-343.
3. Avila NA, Brantly M, Premkumar A, Huizing M, Dwyer A, Gahl WA. Hermansky-Pudlak syndrome: Radiography and CT of the chest compared with pulmonary function tests and genetic studies. AJR Am J Roentgenol 2002; 179: 887-892.
4. Anikster Y, Huizing M, White J, et al. Mutation of a new gene caused a unique form of Hermansky-Pudlak syndrome in a genetic isolate of central Puerto Rico. Nat Genet 2001; 28: 376-380.
5. Bolognia JL, Pawelak NM. Biology of hypopigmentation. J Am Acad Dermatol 1988; 19: 217-255.
6. Witkop CJ, Quevedo WC, Fitzpatrick TB, et al. Albinism. In: Scriver CR, ed. The Metabolic Basis of Inherited Diseases, 6th Ed. New York: Mc Graw Hill, 1989: 105-111.
7. Tomita Y. Tyrosinase gene mutations causing oculocutaneous albinisms. J Invest Dermatol 1993; 100: 1865-1905.
8. Passeron T, Mantoux F, Ortonne JP. Genetic disorders of pigmentation. Clin Dermatol 2005; 23: 56-67.
9. Gahl WA, Brantly M, Kaiser-Kupfer MI, et al. Genetic defects and clinical characteristic of patients with a form of oculocutaneous albimism (Hermansky-Pudlak syndrome). N Engl J Med 1998; 338: 1258-1264.
10. Shanahan F, Randolph L, King R, et al. Hermansky-Pudlak syndrome - an immunologic assessment of 15 cases. Am J Med 1988; 85: 823-828.
11. Schachne JP, Glaser N, Lee SH, et al. Hermansky-Pudlak syndrome - case report and clinicopathological review. J Am Acad Dermatol 1990; 22: 926-932.
12. King RA, Witkop CJ Jr. Hair bulb tyrosinase activity in oculocutaneous albinism. Nature 1976; 263: 69-71.
13. Okoro AN. Albinism in Nigeria. A clinical and social study. Br J Dermatol 1975; 92: 485-492.
14. Taylor WO. Hereditary puzzle in albinisum. Heterogeneity or phenotypical variation? Trans Opthalmol Soc UK 1983; 103: 318-330.
15. Kromberg JG, Jenkins T. Albinism in South African Negro III. Genetic counselling issue. J Blosoc Sci 1984; 16: 99-108.
16. Dube P, Der Kaloustian VM, Demczuk S, et al. A new association of congenital hydrocephalus, albinism, megalocornea, and retinal coloboma in a syndromic child. A clinical and genetic study. Ophthalmic Genet 2000; 21: 211-216.
17. Inagaki K, Suzuki T, Shimizu H, et al. Oculocutaneous albinism type 4 is one of the most common types of albinism in Japan. Am J Hum Genet 2004; 74: 466-471.
18. Ramsay M, Colman MA, Stevens G, et al. The tyrosinase positive oculocutaneous albinism locus maps to chromosome 15Q112-Q12. Am J Hum Genet 1992; 51: 879-884.
19. Hu F, Hanifin JM, Prescott GH, et al. Yellow mutant albinism-cytochemical, ultra-structural and genetic characterization suggesting multiple allelism. Am J Hum Genet 1980; 32: 387-395.
20. Shiloh Y, Litvak G, Ziv Y, et al. Genetic mapping of X-linked albinism-deafness syndrome. (ADFN) to Xq26.3-q27.I. Am J Hum Genet 1990; 47: 20-27.
21. Charles SJ, Green JS, Moore AT, et al. Genetic mapping of X-linked ocular albinism-linkage analysis in a large Newfoundland kindred. Genomic 1993; 16: 259-261.
22. Rebbeck TR, Jordan HA, Schnur RE, et al. Utility of linked markers in genetic counseling: Estimation of carrier risks in X-linked ocular albinism. Am J Med Genet 1997; 70: 58-66.
23. Boissy RE, Nordlund JJ. Molecular basis of congenital hypopigmentary disorders in humans: A review. Pigment Cell Res 1997; 10: 12-24.
24. Oetting WS, King RA. Molecular basis of albinism: Mutations and polymorphism of pigmentation gene associated with albinism. Hum Mutal 1999; 13: 99-115.
25. Incerti B, Cortese K, Pizzigoni A, et al. OA1 knock-out-new insights on the pathogenesis of ocular albinism type I. Hum Mol Genet 2000; 9: 2781-2788.
26. Newton JM, Cohen-Barak O, Hagiwara N, et al. Mutations in the human orthologue of the mouse under-white gene underlie a new form of oculocutaneous albinism OCA4. Am J Hum Genet 2001; 69: 981-988.
27. Toyofuku K, Valencia JC, Kushimoto T, et al. The etiology of oculocutaneous albinism (OCA) type II. The pink protein modulates the processing and transport of tyrosinase. Pigment Cell Res 2002; 15: 217-224.
28. Bergsma DR, Kaiser Kupfer M. A new form of albinism. Am J Opthalmol 1974; 77: 837-844.
29. Busti Rosner L. Two cases of incomplete universal albinism (albinoidism) of a peculiar biotype in a Valais family. J Genet Hum 1956; 5: 197-215.
30. Fulton AB. Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak Syndrome) [correction of (Hennansky-Pudlak)]. Arch Opthol 1999; 117: 251-252.
31. Sagai T, Koide T, Endo M, et al. Rim-2 (recombination induced mutation-2) is a new allele of pearl and a mouse model of human Hermansky-Pudlak syndrome (HPS): Genetic and physical mapping. Mamm Genome 1998; 9: 2-7.
32. Witkop CJ, Krumwiede M, Sedano H, et al. Reliability of absent platelet dense bodies as a diagnostic criteria for Hermansky-Pudlak Syndrome. Am J Haematol 1987; 26: 305-311.
33. Martina JA, Moriyama K, Bonifacino JS. BLOC-3 a protein complex containing the Hermansky-Pudlak syndrome gene products HPS1 and HPS4. J Biol Chem 2003; 278: 29376-29384.
34. Dell'Angelica EC, Sholeler-Suk V, Aguilar RC, et al. Altered trafficking of lysosomal protein in Hermansky-Pudlak Syndrome due to mutations in the beta 3 A sub unit of the AP-3 adapter. Mol Cell 1999; 3: 11-21.
35. Sugita M, Cao X, Watts GF, et al. Failure of trafficking and antigen presentation by CD-1 in AP-3 deficient cells. Immunity 2002; 16: 697-706.
36. Suzuki T, Li W, Zhang Q, et al. The gene mutated in Cocoa mice, carrying a defect in organelle bio-genesis is a homologue of the human Hermansky-Pudlak Syndrome-3 gene. Genomics 2001; 78: 30-37.
37. Zhang Q, Zhao B, Li W, et al. Ru-2 and Ru encode mouse orthologs of the gene mutated in human Hermansky-Pudlak Syndrome types 5 and 6. Nato Genet 2003; 33: 145-153.
38. Li W, Zhang Q, Oiso N, et al. Hermansky-Pudlak Syndrome type 7 results from the mutant dysbinding member of the biogenesis of lysosome-related organdle complex 1 (BLOC-1). Nat Genet 2003; 35: 84-89.
39. Tchernev VT, Mansfield TA, Giot L, et al. The Chediak-Hermansky protein interacts with SNARE complex and signal transduction proteins. Mol Med 2002; 8: 56-64.
40. Faigle W, Raposo G, Tenza D, et al. Deficient peptide loading and MHC class II endosomal sorting in human state - The Chediak Higashi syndrome. J Cell Biol 1998; 141: 1121-1134.
41. Lutzner MA, Lowrie CT, Jorden HW. Giant granules in leukocytes of the beige mouse. J Hered 1967; 58: 299-300.
42. Windhorst DB, Zelickson AS, Good RA. A human pigmentary dilution based on a heritable subcellular structured defect. J Invest Dermatol 1968; 50: 9-18.
43. Padgett GA, Reiquam CW, Gorham JR, et al. Comparative studies of the Chediak Higashi Syndrome. Am J Pathol 1967; 51: 553-571.
44. Choi JH, Hoon SK, Lee KH, et al. Three cases of Waardenburg Syndrome type ×2 in a Korean family. Korean J Opthalmol 2004; 18: 185-189.
45. Denli YG, Yucel A, Gunasti S, et al. A family with Waardenburg syndrome. J Dermatol 2004; 31: 434-436.
46. Nayak CS, Isaacson G. World-wide distribution of Waardenburg syndrome. Ann Otol Rhinol Laryngol 2003; 112: 7-20.
47. Waardenburg PJ. A new syndrome combining developmental anomalies of the eyelid, eyebrows and nose root with pigmentary defects of the iris, head hair with congenital deafness. Am J Human Genet 1951; 3: 195-253.
48. Fisch T. Deafness as a part of an hereditary syndrome. J Laryngol Otol 1959; 73: 355-382.
49. Di George AM, Olmsted RW, Harley RD. Waardenburg's syndrome. A syndrome of heterochromia of the irides, lateral displacement of the medial canthi and lacrimal puncta, congenital deafness, and other characteristic associated defects. Journal of Pediatrics 1960; 57: 649-669.
50. Partington MW. Waardenburg's syndrome and heterochromia iridum in a school population. Cam Med Assoc 1964; 90: 1008-1017.
51. Ortonne JP. Piebaldism, Waardenburg's syndrome and related disorders "Neural crest depigmentation syndromes". Dermatol Clin 1988; 6: 205-216.
52. Toki F, Suzuki N, Inoue K, et al. Intestinal aganglinosis associated with the Waardenburg's syndrome: Report of two cases and review of the literature. Pediatr Surg Int 2003; 19: 725-728.
53. Cant JS, Martin AJ. Waardenburg's syndrome. Report of a family. Br J Opthlomol 1967; 51: 755-759.
54. Madden C, Halsted MJ, Hopken RJ, et al. Temporal bone abnormalities associated with hearing loss in Waardenburg syndrome. Laryngoscope 2003; 113: 2035-2041.
55. Partsch CJ. [Hereditary deafness in Waardenburg-Klein syndrome]. Z Laryngol Rhinol Otol 1962 Nov; 41: 752-762.
56. Reed WB, Stone VM, Boder E, et al. Pigmentary disorders in association with congenital deafness. Arch Dermatol 1967; 95: 176-186.
57. Kaplan P, de Chaderevian JP. Piebaldism - Waardenburg syndrome: Histopathologic evidence for a neural crest syndrome. Am J Med Genet 1988; 31: 679-688.
58. Liu XZ, Newton VE, Read AP. Waardenburg syndrome type II-phenotype findings and diagnostic criteria. Am J Med Genet 1995; 55: 95-100.
59. Perrot H, Ortonne JP, Thivolet J. Ultrastructural study of leukodermic skin in Waardenburg-Klein syndrome. Acta Derm Verereol (Stock) 1977; 57: 195-200.
60. Shah KN, Dalal SJ, Desai MP, et al. White forelock, pigmentary disorder of irides, and long segment Hirschsprung disease: Possible variant of Waardenburg's syndrome. J Pediatr 1981; 99: 432-435.
61. Mosher DB, Fitzpatrick TB. Piebaldism. Arch Dermatol 1988; 124: 364-365.
62. Spritz RA. Piebaldism, Waardernburgs syndrome and related disorders of melanocyte development. Semin Cutan Med Surg 1997; 16: 15-23.
63. Comings DE, Odland GF. Partial albinism. JAMA 1966; 195: 519-523.
64. Cooke JV. Familial white skin spotting (piebaldism) ("partial albinism") with white forelock. J Pediatr 1952; 41: 1-12.
65. Jimbow K, Fitzpatrick TB, Szabo G, et al. Congenital circumscribed hypomelanosis: A characterization based on electron microscopic study of tuberous sclerosis, nevus depigmentosus, and piebaldism. J Invest Dermatol 1975; 64: 50-56.
66. Breathnach AS, Fitzpatrick TB, Wyllie LM. Electron microcopy of melanocytes in human piebaldism. J Invest Dermatol 1965; 45: 28-37.
67. Hayashibe K, Mishima Y. Tyrosinase positive melanocyte distribution and induction of pigmentation in human piebald skin. Arch Dermatol 1988; 124: 381-386.
68. Ward KA, Moss C, Sanders DS. Human piebaldism - relationship between phenotype and site of kit gene mutation. Br J Dermatol 1995; 132: 929-935.
69. Ezoe K, Holmes SA, Ho L, et al. Novel mutations and deletions of the KIT (steel factor receptor) gene in human piebaldism. Am J Hum Genet 1995; 56: 58-66.
70. Giebel LB, Spritz RA. Mutation of the KIT (mast/stem cell growth factor) proto-oncogene in human piebaldism. Proc Natl Acad Sci USA 1991; 88: 8696-8699.
71. Griscelli C, Durandy A, Guy-grand D, et al. A syndrome associating partial albinism and immunodeficiency. Am J Med 1968; 65: 691-702.
72. Rogers SL, Karcher RL, Roland JT, et al. Regulation of melanosomes movement in the cell cycle by reversible association with Myosin V. J Cell Biol 1999; 146: 1265-1276.
73. Bahadoran P, Aberdam E, Mantoux F, et al. Rab 2 7-a: A key to melanosome transport in human melanocytes. J Cell Biol 2001; 152: 843-850.
74. Menasche G, Ho CH, Sanal O, et al. Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A-F exom deletion (GS1). J Clin Invest 2003; 112: 450-456.
75. Glover MT, Brett EM, Atherton DJ. Hypomelanosis of Ito-spectrum of the disease. J Pediatr 1989; 115: 75-80.
76. Flannery DB. Pigmentary dysplasias, hypomelanosis of Ito and genetic Mosaicism. Am J Med Genet 1990; 35: 18-21.
77. Moss C, Burn J. Genetic counselling in hypomelanosis of Ito: Case report and Review. Clin Genet 1988; 34: 109-115.
78. Ruiz-Maldonado R, Toussaint S, Tamayo L, et al. Hypomelanosis of Ito - diagnostic criteria and report of 41 cases. Pediatr Dermatol 1992; 9: 1-10.
79. Ritter CL, Steele MW, Wenger SL. Chromosome mosaicism in hypomelonosis of Ito. Am J Med Genet 1990; 35: 18-21.
80. Hatchwell E. Hypomelanosis of Ito and X-autosome translocations - a unifying hypothesis. J Med Genet 1996; 33: 177-183.
81. Duran-McKinster C, Moises C, Rodriguez-Jurado R, et al. Streptococcal exanthem in Blaschko-linear pattern - clinical evidence for genetic mosaicism in hypomelanosis of Ito. Pediatr Dermatol 2002; 19: 423-425.
82. Kuster W, Konig A. Hypomelanosis of Ito - no entity but a cutaneous sign of Mosaicism. Am J Med Genet 1999; 85: 346-350.
83. Nehal KS, PeBenito R, Orlow SJ. Analysis of 54 cases of hypopigmentation and hyperpigmentation along the lines of Blaschko. Arch Dermatol 1996; 132: 1167-1170.
84. Bolognia JL, Orlow SJ, Glick SA. Lines of Blaschko. J Am Acad Dermatol 1994; 31: 157-190.
85. Ruggieri M. Familial hypomelanosis of Ito - implications for genetic counseling. Am J Med Genet 2000; 95: 82-84.
86. Steijlen PM, Vietor HE, Steensel MV, et al. Sweat testing in hypomelanosis of Ito divergent results reflecting genetic heterogeneity. Eur J Dermatol 2000; 10: 217-219.
87. Gutman I, Dunn D, Behrens M, et al. Hypopigmented iris spot - an early sign of tuberous sclerosis. Ophthalmology 1982; 89: 1155-1159.
88. Awan KJ. Leaf-shaped lesions of the ocular fundus and white eyelashes in tuberous sclerosis. South Med J 1982; 75: 227-228.
89. Winship IM, Connor JM, Beighton PH. Genetic heterogeneity in tuberous sclerosis - phenotypic correlation. J Med Genet 1990; 27: 418-421.
90. Hurwitz S, Braverman IM. White spots in tuberous sclerosis. J Pediatr 1970; 77: 587-594.
91. Fitzpatrick TB, Szabo G, Hori Y, et al. White leaf-shaped macules. Earliest visible sign of tuberous sclerosis. Arch Dermatol 1968; 98: 1-6.
92. Sampson JR, Harris PC. The molecular genetics of tuberous sclerosis. Hum Mol Genet 1994; 3: Spec No: 1477-1480.
93. Van Slegtenhorst M, de Hoogt R, Hermans C, et al. Identification of the tuberous sclerosis gene TSC-1 and chromosome 9q34. Science 1997; 227: 805-808.
94. Benvenuto G, Li S, Brown SJ, et al. The tuberous sclerosis -1 (TSC-1) gene product hamartin suppresses cell growth product tuberin by inhibiting its ubiquitinations. Oncogene 2000; 19: 6306-6316.
95. Hyman MH, Whittemore VH. National Institute of Health consensus conference: Tuberous sclerosis complex. Arch Neurol 2000; 57: 662-665.
96. Zvulunov A, Esterly NB. Neurocutaneous syndrome associated with pigmentary skin lesions. J Am Acad Dermatol 1995; 32: 915-935.
97. Di Lermia V. Segmental nerves depigmentosus - analysis of 20 patients. Pediatr Dermatol 1999; 16: 349-353.
98. Fukai K, Ishil M, Kadoya A, et al. Nevus depigmentosus systematicus with partial yellow scalp hair due to selective suppression of eumelanogenesis. Pediatr Dermatol 1993; 10: 205-208.
99. Kirkilionis AJ, Chudley AE, Gregory CA, et al. Molecular and clinical overlap of Angelman and Prader-Willi Syndrome phenotypes. Am J Med Genet 1991; 40: 454.
100. Tietz W. A syndrome of deaf-mutism associated with albinism showing dominant autosomal inheritance. Am J Hum Genet 1963; 15: 259-264.
101. Ziprkowski L, Krakowski A, Adam A, et al. Partial albinism and deaf-mutism due to a recessive sex-linked gene. Arch Dermatol 1962; 86: 530-539.
102. Cross He, McKusick VA, Breen W. A new oculocerebral syndrome with hypopigmetation. J Pediater 1976; 70: 398-406.
103. Sehgal VN, Srivastava G. Vitiligo: Auto-immunity and immune responses. Int J Dermatol 2006; 45: 583-590.
104. Spritz RA, Gowan K, Bennett DC, et al. Novel vitiligo susceptibility loci chromosome -7 (A1S2) and -8 (A1S3), confirmation of SLEV-1 on chromosome-17, and their role in an autoimmune diathesis. Am J Hum Genet 2004; 74: 188-191.
105. Fain PR, Gowan K, LaBerge GS, et al. A genome wide screen for generalized vitiligo confirmation of A1S1 on chromosome Ip31 and evidence for additional susceptibility loci. Am J Hum Genet 2003; 72: 1560-1564.
106. Alkhateeb A, Stekler GL, Old W, et al. Mapping of an autoimmunity susceptibility locus (A1S1) to chromosome 1p31.3-p32.2. Hum Mol Genet 2002; 11: 661-667.
107. Kopf AW, Morrill SD, Silberberg I. Broad spectrum of leukoderma acquisitum centrifugum. Arch Dermatol 1965; 92: 14-35.
108. Ortonne JP. Halo nevus. In: Ortonne JP, Mosher DB, Fitzpatrick TB, eds. Vitiligo and other hypomelonosis of hair and skin, 1st edn. New York, NY: Plenum Medical, 1983: 567-582.
109. Wayte DM, Helwig EB. Helo nevi. Cancer 1968; 22: 69-70.
110. Copeman PW, Lewis MG, Phillips TM, et al. Immunological associations of the halo naevus with cutaneous malignant melanoma. Br J Dermatol 1973; 88: 127-137.
111. Gauthier Y, Surleve-Bazeille JE, Gauther O. Ultrastructure of halo nevis. J Cutan Pathol 1975; 2: 71-81.
112. Swanson JL, Wayte DM, Helwig EB. Ultrastructure of halo nevi. J Invest Dermatol 1968; 50: 434-437.
113. Fleisher TL, Zeligman I. Cutanoeus findings in phenylketonuria. Arch Dermatol 1960; 81: 818-902.
114. Woolf LI. Phenylketonuria and its variant. West J Med 1979; 131: 324-328.
115. Kaufman S. Differential diagnosis of variant forms of hyperphenylalanemia. Pediatrics 1980; 65: 840-844.
116. Brenton DP, Cusworth DC, Biddle SA, et al. Pregnancy and homocystinuria. Ann Clin Biochem 1977; 14: 161-164.
117. Grieco AJ. Homo-cystinuria - pathogenetic mechanism. Am J Med Sci 1977; 273: 120-124.
118. Woody NC, Synder CH, Harris JA. Histidinemia. Am J Dis Child 1965; 110: 606-608.
119. Danks DM, Campbell PE, Walker-Smith J, et al. Menke's kinky hair syndrome. Lancet 1972; 1: 1100-1101.